Prodromal Parkinson disease in patients with idiopathic hyposmia.

Journal of Neurology
Paula Marrero-GonzálezJoaquim Mullol

Abstract

Idiopathic hyposmia (IH) is a prodromal marker of Parkinson disease (PD). However, IH is common in the general population and only a minority will develop PD. Identification of individuals with IH at prodromal stage of PD would serve to select them to implement neuroprotective agents, when available. To identify prodromal PD in IH patients using the Movement Disorders Society (MDS) research criteria for prodromal PD. We applied the MDS research criteria for prodromal PD to 25 consecutive patients older than 50 years who were self-referred for smell loss and had IH, and to 18 controls. A number of risk and prodromal PD markers were assessed in all participants including REM sleep behavior disorder (RBD) by video-polysomnography and nigrostriatal dopaminergic dysfunction by DAT-SPECT. After follow-up of 4.7 ± 2.2 years, participants were re-assessed to look for incident PD. Prodromal PD probability was higher in patients than in controls (19.45 ± 34.9% versus 1.74 ± 4.48%; p = 0.019). Four (16%) patients met the criteria of prodromal PD surpassing 80% probability (99.8%, 99.5%, 88.3%, 86.4%). Three (12%) patients had RBD and four (16%) abnormal DAT-SPECT. At the end of follow-up, one (4%) IH patient who had RBD and baseline prodr...Continue Reading

References

Oct 1, 1991·Brain : a Journal of Neurology·J M Fearnley, A J Lees
Jul 1, 1983·Neurology·C D WardD B Calne
Aug 6, 2000·Movement Disorders : Official Journal of the Movement Disorder Society·H T BenamerD G Grosset
Feb 24, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·G TissinghE C Wolters
Nov 13, 2002·JAMA : the Journal of the American Medical Association·Claire MurphyDavid M Nondahl
Apr 3, 2003·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher Hawkes
Aug 5, 2004·Annals of Neurology·Mirthe M PonsenHenk W Berendse
Apr 9, 2005·Journal of the American Geriatrics Society·Ziad S NasreddineHoward Chertkow
May 9, 2006·Gastroenterology·George F LongstrethRobin C Spiller
May 23, 2006·Lancet Neurology·Lonneke M L de Lau, Monique M B Breteler
Oct 10, 2006·Brain Research Bulletin·Maria Livia FantiniLuigi Ferini-Strambi
Mar 16, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Antje HaehnerHeinz Reichmann
Dec 11, 2007·Annals of Neurology·G Webster RossLon R White
Nov 26, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Christopher G GoetzUNKNOWN Movement Disorder Society UPDRS Revision Task Force
Jun 11, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Paolo BaroneUNKNOWN PRIAMO study group
Mar 4, 2011·Movement Disorders : Official Journal of the Movement Disorder Society·Alexandra GaenslenDaniela Berg
Mar 25, 2011·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·Roy FreemanJ Gert van Dijk
Jan 13, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Andrew SiderowfUNKNOWN PARS Investigators
Jun 2, 2012·Sleep·Birgit FrauscherUNKNOWN SINBAR (Sleep Innsbruck Barcelona) Group
Sep 21, 2012·Journal of Neurology, Neurosurgery, and Psychiatry·Roberto ErroPaolo Barone
Jan 16, 2013·Neurology·Tien K KhooDavid J Burn
Mar 27, 2013·Parkinsonism & Related Disorders·Alex IranzoEduardo Tolosa
Oct 10, 2014·Neurology·Danna JenningsUNKNOWN PARS Investigators
Dec 3, 2014·Movement Disorders : Official Journal of the Movement Disorder Society·Claustre Pont-SunyerEduardo Tolosa
Jan 23, 2015·Neurology·Philipp MahlknechtUNKNOWN Sleep Innsbruck Barcelona Group
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Ronald B PostumaGünther Deuschl
Oct 17, 2015·Movement Disorders : Official Journal of the Movement Disorder Society·Daniela BergGünther Deuschl
Oct 21, 2015·Journal of Parkinson's Disease·Philipp MahlknechtWerner Poewe
Feb 6, 2016·Journal of Neurology, Neurosurgery, and Psychiatry·Alastair John NoyceAnette-Eleonore Schrag
Jun 9, 2016·Movement Disorders : Official Journal of the Movement Disorder Society·Philipp MahlknechtKlaus Seppi
Oct 28, 2016·Nature Reviews. Neurology·Ronald B Postuma, Daniela Berg
Jan 17, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Alastair J NoyceAnette Schrag
Apr 4, 2017·Neurología : publicación oficial de la Sociedad Española de Neurología·C DelgadoM I Behrens
Apr 22, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Seyed-Mohammad FereshtehnejadRonald B Postuma
May 17, 2017·Movement Disorders : Official Journal of the Movement Disorder Society·Andrea PilottoDaniela Berg
Jun 9, 2017·JAMA Neurology·Danna JenningsUNKNOWN PARS Investigators
Jun 16, 2017·Neurology·Alex IranzoUNKNOWN SINBAR (Sleep Innsbruck Barcelona) group

❮ Previous
Next ❯

Citations

Oct 22, 2021·Chemical Senses·Emily J Papazian, Jayant M Pinto

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Progress in Brain Research
Eva SchaefferDaniela Berg
Journal of the International Neuropsychological Society : JINS
Christine A Cooper, Lama M Chahine
Movement Disorders : Official Journal of the Movement Disorder Society
Daniela BergGünther Deuschl
© 2021 Meta ULC. All rights reserved